Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

DE:OM3E ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

DE:OM3E Analyst Ratings

Moderate Buy
245ConsensusRatings
222Buy22Hold1Sell
Based on the Wall Street analyst consensus for 245 of DE:OM3E’s holdings.

DE:OM3E 12 Month Forecast

$11.98▲(32.67% Upside)
Based on Wall Street analyst 12-month price targets for 245 of iShares NASDAQ US Biotechnology UCITS ETF’s holdings in the last 3 months. The average price target is $11.98 with a high forecast of $15.37 and a low forecast of $8.57. The average price target represents a 32.67% change from the last price of $9.03.
Highest Price Target$15.37Average Price Target$11.98Lowest Price Target$8.57

DE:OM3E Stocks With Highest Upside Potential

DE:OM3E highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$13.00(3086.27% Upside)
Strong Buy$10.00(1597.79% Upside)
Strong Buy$5.25(1239.29% Upside)
Strong Buy$6.75(994.00% Upside)
Strong Buy$14.67(986.42% Upside)

DE:OM3E Stocks With Highest Downside Potential

DE:OM3E highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$6.00(-44.70% Downside)
Hold$127.69(-35.79% Downside)
Hold$53.45(-17.90% Downside)
Moderate Sell$3.00(-17.58% Downside)
Moderate Buy$105.86(-17.31% Downside)

DE:OM3E ETF FAQ

What is DE:OM3E’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 245 of DE:OM3E’s holdings, iShares NASDAQ US Biotechnology UCITS ETF’s 12-month average price target is $11.98.
What is DE:OM3E’s upside potential, based on the analysts’ average price target?
DE:OM3E’s average price target of $11.98 represents a 32.67% upside from its last price of $9.03.
Is DE:OM3E a Buy, Sell or Hold?
iShares NASDAQ US Biotechnology UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 245 of DE:OM3E’s holdings: 222 rated Buy, 22 rated Hold and 1 rated Sell.
What is iShares NASDAQ US Biotechnology UCITS ETF’s price target?
The average price target for iShares NASDAQ US Biotechnology UCITS ETF is $11.98, based on Wall Street analyst 12-month price targets for 245 of DE:OM3E’s holdings, issued in the past 3 months. The highest price target is $15.37 and the lowest is $8.57. The average price target represents a 32.67% increase from the last price of $9.03.
What is DE:OM3E’s expense ratio?
DE:OM3E’s expense ratio is 0.37%.
How many holdings does DE:OM3E have?
DE:OM3E holds 247 assets.
How can I buy shares of DE:OM3E?
You can buy shares of DE:OM3E through a brokerage account. Compare brokers on our Best Online Brokers page.